+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

High-power potassium-titanyl-phosphate laser fibres for endovaporization of benign prostatic hyperplasia: how much do they deteriorate during the procedure?



High-power potassium-titanyl-phosphate laser fibres for endovaporization of benign prostatic hyperplasia: how much do they deteriorate during the procedure?



Bju International 107(12): 1938-1942



• To assess the residual power delivered at the tip of a high-power (80 W) potassium-titanyl-phosphate (KTP) laser (80 W Green Light PV(TM), Laserscope(®); American Medical Systems, Minnetonka, MN, USA) at the end of a photoselective vaporization of the prostate (PVP) procedure, as well as the deflection angle of the laser beam. • In total, 65 laser fibres were collected at the end of PVP procedures indicated for symptomatic benign prostatic hyperplasia over a period of 17 months. PVP was performed by two senior urologists. • The power of laser beam at tip exit was measured for each fibre at the end of the procedures using a photodiode whose signal was amplified, and then quantified by a volt multimeter. • The deflection angle was measured using a graduated sphere. • Approximately 70% of fibres delivered less than 40 W at the end of the procedure, which is less than the vaporization threshold. • Some 9% of fibres had lost their diffraction capacity with a significant alteration of laser beam angulation. These values were not operator dependent. • The data show that a large proportion of laser fibers deliver a significantly underpowered beam at the end of the procedures. • This seems to be caused by peroperative destruction of the fibers, which results in a progressive loss of efficacy of PVP during procedures.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 053548156

Download citation: RISBibTeXText

PMID: 21040366

DOI: 10.1111/j.1464-410x.2010.09760.x


Related references

Experiences in the treatment of benign prostatic hyperplasia with high power potassium-titanyl-phosphate (KTP) laser. Wiadomosci Lekarskie 59(3-4): 196-198, 2006

Photoselective Vaporization Of The Prostate (Pvp) Using 80 Watt High Power Potassium-Titanyl-Phosphate (Ktp) Laser For Benign Prostatic Hyperplasia. The Japanese Journal of Urology 97(7): 815-822, 2006

High-power potassium-titanyl-phosphate laser photoselective vaporization prostatectomy for symptomatic benign prostatic hyperplasia. Journal of Endourology 22(6): 1311-1314, 2008

High-power potassium-titanyl-phosphate photoselective laser vaporization of prostate for treatment of benign prostatic hyperplasia in men with large prostates. Urology 64(6): 1155-1159, 2004

High-power potassium-titanyl-phosphate or lithium triboride laser photoselective vaporization prostatectomy for benign prostatic hyperplasia: a systematic approach. Journal of Endourology 21(10): 1141-1144, 2007

Photoselective vaporization of the prostate (PVP) using 80 watt high power potassium-titanyl-phosphate (KTP) laser for benign prostatic hyperplasia: the first fifty-seven patients in Japan. Nihon Hinyokika Gakkai Zasshi. Japanese Journal of Urology 97(7): 815-822, 2006

Comment to the study: experiences in the treatment of benign prostatic hyperplasia with high power potassium-titanyl-phosphate (KTP). Wiadomosci Lekarskie 59(3-4): 292-292, 2006

Stone formation in prostatic urethra after potassium-titanyl-phosphate laser ablation of the prostate for benign prostatic hyperplasia. Journal of Endourology 23(11): 1879-1881, 2009

Safety and efficacy of the potassium-titanyl-phosphate laser and photoselective vaporization of the prostate for benign prostatic hyperplasia. Reviews in Urology 8(Suppl. 3): S16-S23, 2006

Potassium-titanyl-phosphate (KTP)/lithium triboride (LBO) laser photoselective vaporization prostatectomy (PVP) for benign prostatic hyperplasia (BPH): A systematic approach. 2007

Potassium-titanyl-phosphate laser photoselective vaporization for benign prostatic hyperplasia: 5-year follow-up from a district general hospital. Journal of Endourology 26(7): 878-883, 2012

Evaluation of a KTP (potassium-titanyl-phosphate) 532 nm laser for endovaporization of choroidal melanomas. Lasers in Surgery and Medicine 36(1): 57-64, 2005

The Efficacy and Safety of Photoselective Vaporization of the Prostate with a Potassium-titanyl-phosphate Laser for Symptomatic Benign Prostatic Hyperplasia according to Prostate Size: 2-Year Surgical Outcomes. Korean Journal of Urology 51(5): 330-336, 2010

Clinical outcome of potassium-titanyl-phosphate (KTP/532) laser vaporization prostatectomy for benign prostate hyperplasia. Nihon Hinyokika Gakkai Zasshi. Japanese Journal of Urology 92(4): 498-505, 2001

High-power potassium titanyl phosphate laser vaporization prostatectomy. Mayo Clinic Proceedings 73(8): 798-801, 1998